You prove my point in another post of mine @Mom88. Biotechs have been sold down horrendously over the last few years and will always be able to raise money if they have viable IP. I can see Osteopore is just one of many biotechs which may rise substially in the future once their products are approved.
Ann: Prospectus for Renounceable Rights Issue, page-34
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.645M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 130146 | 3 |
View Market Depth
| Last trade - 10.16am 28/06/2024 (20 minute delay) ? |
| OSX (ASX) Chart |
Day chart unavailable